Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11668 | 30796899 | Clin Chim Acta | Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation. | 2019 | Details |
| A11669 | 30796701 | Indian J Gastroenterol | Legume intake and risk of nonalcoholic fatty liver disease. | 2019 | Details |
| A11670 | 30796508 | Eur J Nutr | Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A11671 | 30794826 | Toxicol Appl Pharmacol | Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. | 2019 | Details |
| A11672 | 30794635 | PLoS One | NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. | 2019 | Details |
| A11673 | 30794300 | JAMA Netw Open | Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2019 | Details |
| A11675 | 30793973 | Genet Test Mol Biomarkers | Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11676 | 30793717 | Food Funct | Activated TNF-α/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: inhibition by dietary fisetin intervention. | 2019 | Details |
| A11678 | 30793550 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis. | 2019 | Details |
| A11679 | 30792450 | Sci Rep | Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1. | 2019 | Details |
| A11680 | 30792163 | Arch Med Res | Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. | 2019 | Details |
| A11681 | 30791794 | Expert Rev Gastroenterol Hepatol | Sarcopenia and chronic liver diseases. | 2018 | Details |
| A11683 | 30791782 | Expert Rev Gastroenterol Hepatol | Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. | 2018 | Details |
| A11684 | 30791778 | Expert Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. | 2018 | Details |
| A11685 | 30791768 | Expert Rev Gastroenterol Hepatol | The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies. | 2019 | Details |
| A11686 | 30791767 | Expert Rev Gastroenterol Hepatol | Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. | 2019 | Details |
| A11688 | 30790345 | Fundam Clin Pharmacol | A population analysis of the DGAT1 inhibitor GSK3008356 and its effect on endogenous and meal-induced triglyceride turnover in healthy subjects. | 2019 | Details |
| A11689 | 30790285 | J Cell Physiol | Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease. | 2019 | Details |
| A11690 | 30790016 | Rheumatol Int | Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis. | 2019 | Details |
| A11691 | 30789865 | J Pediatr Gastroenterol Nutr | Free-breathing Magnetic Resonance Imaging Assessment of Body Composition in Healthy and Overweight Children: An Observational Study. | 2019 | Details |
| A11692 | 30789808 | Int J Vitam Nutr Res | No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11693 | 30789804 | Int J Vitam Nutr Res | Liver Histological Improvement After Administration of High-Dose Vitamin C in Guinea Pig with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11695 | 30788772 | J Endocrinol Invest | Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. | 2019 | Details |
| A11696 | 30788556 | Abdom Radiol (NY) | Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11697 | 30788048 | World J Diabetes | SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11699 | 30787626 | Diabetes Metab Syndr Obes | Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11701 | 30787418 | Sci Rep | Transcriptional regulation of Hepatic Stellate Cell activation in NASH. | 2019 | Details |
| A11702 | 30786957 | J Pharm Pharm Sci | Effects of Orotic Acid-Induced Non-Alcoholic Fatty Liver on the Pharmacokinetics of Metoprolol and its Metabolites in Rats. | 2019 | Details |
| A11703 | 30786689 | Pol J Pathol | Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients. | 2019 | Details |
| A11704 | 30786346 | Zhonghua Yi Xue Za Zhi | [Application of stretched exponential diffusion-weighted imaging model in quantitative diagnosis of nonalcoholic fatty liver disease: in a rabbit model]. | 2019 | Details |
| A11705 | 30785444 | Food Funct | Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease. | 2019 | Details |
| A11706 | 30784251 | Minerva Med | Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. | 2019 | Details |
| A11707 | 30783901 | Hepatol Int | End-points for drug treatment in NASH. | 2019 | Details |
| A11708 | 30783789 | Eur Radiol | Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD. | 2019 | Details |
| A11709 | 30783412 | ARYA Atheroscler | Dill-normalized liver lipid accumulation, oxidative stress, and low-density lipoprotein receptor levels in high cholesterol fed hamsters. | 2018 | Details |
| A11710 | 30782709 | BMJ Open | Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. | 2019 | Details |
| A11711 | 30782153 | BMC Musculoskelet Disord | Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report. | 2019 | Details |
| A11712 | 30781653 | Nutrients | Eucommia ulmoides Leaf Extract Ameliorates Steatosis Induced by High-fat Diet in Rats by Increasing Lysosomal Function. | 2019 | Details |
| A11713 | 30781472 | Antioxidants (Basel) | Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. | 2019 | Details |
| A11714 | 30780126 | Pharmacol Rep | Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A11715 | 30779990 | Clin Gastroenterol Hepatol | Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11717 | 30778334 | Front Endocrinol (Lausanne) | Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health. | 2019 | Details |
| A11719 | 30778201 | Cell Death Differ | The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. | 2019 | Details |
| A11720 | 30778102 | Sci Rep | Identification of FDA-approved drugs targeting the Farnesoid X Receptor. | 2019 | Details |
| A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
| A11722 | 30776459 | Toxicology | Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C/EBPα-SIRT1 pathway. | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11724 | 30776032 | Food Funct | Myricetin alleviated hepatic steatosis by acting on microRNA-146b/thyroid hormone receptor b pathway in high-fat diet fed C57BL/6J mice. | 2019 | Details |
| A11725 | 30775610 | Arch Med Sci Atheroscler Dis | Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study. | 2018 | Details |
| A11726 | 30774848 | Int J Prev Med | Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials. | 2019 | Details |
| A11727 | 30774801 | Gastroenterol Hepatol Bed Bench | Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A11728 | 30774403 | Diabetes Metab Syndr Obes | The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. | 2019 | Details |
| A11729 | 30774269 | World J Gastroenterol | Iron and liver fibrosis: Mechanistic and clinical aspects. | 2019 | Details |
| A11730 | 30773868 | Zhen Ci Yan Jiu | [Progress of researches on acupuncture treatment of diseases by regulating endoplasmic reticulum stress]. | 2019 | Details |
| A11731 | 30773673 | Clin Exp Pharmacol Physiol | Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation. | 2019 | Details |
| A11732 | 30772951 | J Cell Mol Med | Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice. | 2019 | Details |
| A11733 | 30772307 | EBioMedicine | Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A11734 | 30772256 | Mol Metab | Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. | 2019 | Details |
| A11736 | 30770929 | Carcinogenesis | MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. | 2020 | Details |
| A11737 | 30770629 | Diabetes Metab Res Rev | Gall bladder: The metabolic orchestrator. | 2019 | Details |
| A11738 | 30770336 | Clin Res Hepatol Gastroenterol | Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions. | 2019 | Details |
| A11739 | 30770098 | Biochem Biophys Res Commun | Genetic deletion of β2 adrenergic receptors exacerbates hepatocellular lipid accumulation in high-fat diet mice. | 2019 | Details |
| A11740 | 30770094 | Cell Immunol | Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease. | 2019 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |
| A11743 | 30769284 | Redox Biol | Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A11744 | 30769007 | J Hepatol | The degree of hepatic steatosis associates with impaired cardiac and autonomic function. | 2019 | Details |
| A11745 | 30768879 | Klin Lab Diagn | [The person in philogenesis is not (omnivores), but the herbivores with the carnivores past and the fuzzy future. Biological function of trophology (nutrition) in ontogenesis.] | 2019 | Details |
| A11746 | 30767788 | BMC Res Notes | Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial. | 2019 | Details |
| A11747 | 30767679 | Am J Physiol Gastrointest Liver Physiol | Role of ketone signaling in the hepatic response to fasting. | 2019 | Details |
| A11748 | 30767421 | Diabetes Metab Res Rev | The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis. | 2019 | Details |
| A11749 | 30766961 | Hepatol Commun | Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity. | 2018 | Details |
| A11750 | 30766955 | Hepatol Commun | Intestinal Lipolysis Mitigates Nonalcoholic Fatty Liver Disease: New Roles for Carboxylesterase 2c in the Intestine. | 2019 | Details |
| A11751 | 30766414 | Fed Pract | Identifying and Treating Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11752 | 30766413 | Fed Pract | Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans. | 2019 | Details |
| A11753 | 30765936 | J Clin Exp Hepatol | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. | 2018 | Details |
| A11754 | 30765935 | J Clin Exp Hepatol | Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease. | 2017 | Details |
| A11755 | 30765934 | J Clin Exp Hepatol | Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. | 2018 | Details |
| A11756 | 30765737 | Sci Rep | Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH. | 2019 | Details |
| A11757 | 30763931 | Cerebrovasc Dis | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients. | 2019 | Details |
| A11758 | 30763699 | Diabetes Metab | Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. | 2019 | Details |
| A11759 | 30763486 | Vopr Pitan | [Effect of quercetin on morphological changes in nonalcoholic fatty liver disease in high fructose-fed rats]. | 2018 | Details |
| A11761 | 30762938 | Mol Nutr Food Res | Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice. | 2019 | Details |
| A11762 | 30762732 | Medicine (Baltimore) | Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis. | 2019 | Details |
| A11763 | 30762163 | Drug Saf | Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A11764 | 30761572 | Aliment Pharmacol Ther | Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. | 2019 | Details |
| A11765 | 30761559 | Aliment Pharmacol Ther | Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. | 2019 | Details |
| A11766 | 32598624 | Ter Arkh | [Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis]. | 2019 | Details |
| A11767 | 30759431 | Ann Nutr Metab | Low Levels of Serum β-Carotene and β-Carotene/Retinol Ratio Are Associated with Histological Severity in Nonalcoholic Fatty Liver Disease Patients. | 2019 | Details |
| A11768 | 30759275 | Mol Genet Genomics | Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model. | 2019 | Details |
| A11769 | 30758417 | Rev Assoc Med Bras (1992) | The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data. | 2019 | Details |
| A11770 | 30758165 | J Sports Med Phys Fitness | Aerobic capacity and exercise performance in nonalcoholic fatty liver disease. | 2019 | Details |
| A11771 | 30757944 | Pharm Biol | Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat. | 2019 | Details |
| A11772 | 30756471 | J Dig Dis | Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population. | 2019 | Details |
| A11773 | 30755994 | Eur J Case Rep Intern Med | Mauriac Syndrome: A Rare Complication of Type 1 Diabetes Mellitus. | 2018 | Details |
| A11774 | 30755685 | Sci Rep | Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. | 2019 | Details |
| A11775 | 30755499 | Clin Sci (Lond) | Emerging awareness on the importance of skeletal muscle in liver diseases: time to dig deeper into mechanisms! | 2019 | Details |
| A11777 | 30753863 | Eur J Pharmacol | Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. | 2019 | Details |
| A11778 | 30748020 | Hepatology | Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice. | 2019 | Details |